HSP90B1 and central nervous system cancer: Our results demonstrated that gp96 was overexpressed in grade IV gliomas (Figure 1(b)), and high gp96 expression was associated with unfavorable outcomes, independent of the malignancy grade (Figures 2(d)–2(i)).